Area of research
Biomaterials · Biomedical Engineering
Research interest
Research interests include Nanoparticle-Based Drug Delivery, Nanoplatforms for cancer theranostics, Immunotherapy and Immune Responses, and Cancer Cells and Metastasis.
Recommendations for mitochondria transfer and transplantation nomenclature and characterization
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy
An architecturally rational hemostat for rapid stopping of massive bleeding on anticoagulation therapy
Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells
Engineered cell-laden alginate microparticles for 3D culture
Human Nonalcoholic Steatohepatitis on a Chip
Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence
Organ‐on‐a‐Chip for Cancer and Immune Organs Modeling
Reporter nanoparticle that monitors its anticancer efficacy in real time
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype
Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy